Tal Zaks, Chief Medical Officer at Moderna, discusses groundbreaking mRNA vaccine technology. Peggy Hamburg, former FDA commissioner, highlights the ethical and public health challenges in vaccine distribution. Andrew Lowe, a financial economist, offers insights into innovative funding models for medical research. They explore the rapid advancements in vaccine development during COVID-19, the importance of global equity in access, and the long-term implications for healthcare and pandemic preparedness.
